VPS9D1-AS1 and breast cancer: Kaplan‐Meier analysis showed that high expression of FAISL predicted poor overall survival in the breast cancer cohort (all subtypes together) (p = 1.3e‐05, hazard ratio (HR) = 3.09) and the TNBC cohort (p = 0.022, HR = 3.77) (Figure 1N,O).